Clarithromycin and Diffuse alveolar damage - a phase IV clinical study of FDA data

Summary:

Diffuse alveolar damage is reported as a side effect among people who take Clarithromycin (clarithromycin), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Ventolin, and have Pain.

The phase IV clinical study analyzes which people have Diffuse alveolar damage when taking Clarithromycin. It is created by eHealthMe based on reports of 44,030 people who have side effects when taking Clarithromycin from the FDA, and is updated regularly.

What is Clarithromycin?

Clarithromycin has active ingredients of clarithromycin. It is often used in sinusitis. eHealthMe is studying from 45,044 Clarithromycin users. Check the latest studies of Clarithromycin.

What is Diffuse alveolar damage?

Diffuse alveolar damage (common manifestation of drug-induced lung injury) is found to be associated with 147 drugs and 361 conditions by eHealthMe. Check the latest studies of Diffuse alveolar damage.

On Jul, 06, 2026

44,030 people reported to have side effects when taking Clarithromycin.
Among them, 54 people (0.12%) have Diffuse alveolar damage.

Could Clarithromycin cause Diffuse alveolar damage?

Among these 54 people:

How long have people been on Clarithromycin when they have Diffuse alveolar damage? *

What is the gender of people who have Diffuse alveolar damage when taking Clarithromycin? *

female: 24.49 %
male: 75.51 %

What is the age of people who have Diffuse alveolar damage when taking Clarithromycin? *

What are other drugs people take besides Clarithromycin? *

What are other side effects people have besides Diffuse alveolar damage? *

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 26 people, 48.15%
Headache (pain in head): 22 people, 40.74%
C-Reactive Protein Increased: 22 people, 40.74%
Rashes (redness): 22 people, 40.74%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 21 people, 38.89%
Malaise (a feeling of general discomfort or uneasiness): 21 people, 38.89%
Heart Rate Increased: 21 people, 38.89%
Fever: 21 people, 38.89%
Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 21 people, 38.89%
Nausea And Vomiting: 21 people, 38.89%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 21 people, 38.89%
Pain: 21 people, 38.89%
Lower Respiratory Tract Infection: 19 people, 35.19%
Stress And Anxiety: 18 people, 33.33%
Gastritis (inflammation of stomach): 18 people, 33.33%
Rickets (softening of bones): 12 people, 22.22%
Bone Disorder: 10 people, 18.52%
Indigestion: 10 people, 18.52%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 10 people, 18.52%
Upper Respiratory Tract Infection: 9 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Clarithromycin and have Diffuse alveolar damage?

- Check whether Diffuse alveolar damage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clarithromycin:

Clarithromycin (45,044 reports)

Browse all side effects of Clarithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Diffuse alveolar damage:

Diffuse alveolar damage (147 drugs)

Browse all the conditions that are associated with Diffuse alveolar damage:

Diffuse alveolar damage (361 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clarithromycin (the active ingredients of Clarithromycin) and Clarithromycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.